UK mission looking to boost Asian pharma and other trade
This article was originally published in Scrip
Executive Summary
The UK minister for trade and investment, Gareth Thomas, is on a mission through Southeast Asia to highlight the opportunities for UK firms in this comparatively fast-growing region, including in the pharma sector. He will also stress the benefits of investing in the UK and of partnering with British business. The mission starts this week in Singapore and then moves to Taiwan, where Mr Thomas will call for a reduction in regulations and improved market access. Regular reimbursement price reductions and the dominance of the local generics-based industry have been particular concerns for foreign R&D-based drug firms in this market. The minister will also visit Vietnam and Malaysia.
You may also be interested in...
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: another big deal in radiopharmaceuticals; BioNTech’s ADC pipeline; China CDMOs embrace uncertain future; at look at the rivals in MASH; and industry views on how AI might be transformative.
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: Galderma prepares to take on Dupixent; Pfizer’s plans for Adcetris in DLBCL; Lilly’s donanemab approval delayed again; the psychedelic R&D pipeline; and an interview with BMS’s CDTO Greg Meyers.
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: Bayer won’t split, for now; Pfizer’s next-gen ADC pipeline; oncology dominates investment but other areas grow; goodbye NASH, hello MASH; and BMS’s CEO gives his views on India.